Bo Wang
4PUBLICATIONS
17CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jul 27, 2024
NAD+ metabolism enzyme NNMT in cancer-associated fibroblasts drives tumor progression and resistance to immunotherapy by modulating macrophages in urothelial bladder cancer.Meihua Yang, Bo Wang, Weibin Hou
|Apr 08, 2024
Type III interferon inhibits bladder cancer progression by reprogramming macrophage-mediated phagocytosis and orchestrating effective immune responses.Bo Wang, Bingkun Zhou, Junyu Chen
|Oct 17, 2023
Effective Antitumor Immunity Can Be Triggered by Targeting VISTA in Combination with a TLR3-Specific Adjuvant.Bo Wang, Ziwei Ou, Wenlong Zhong
|Feb 19, 2021
Development and validation of a PD-L1/PD-1/CD8 axis-based classifier to predict cancer survival of upper tract urothelial carcinoma after radical nephroureterectomy.Junyu Chen, Wenlong Zhong, Meng Yang
Pageof 1
Frequent Collaborators
2 joint publications
Jian Huang
2 joint publications
Hao Yu
1 joint publications
Ziwei Ou
1 joint publications
Wenlong Zhong
1 joint publications
Lin Huang
1 joint publications
Wenjian Liao
1 joint publications
Yiyu Sheng
1 joint publications
Zhixing Guo
1 joint publications
Meihua Yang
1 joint publications
Wenjuan Yang
